Infections

A case study has tracked, for the first time, the movement of antibiotic-resistant bacteria from a patient's gut microbiome to their lungs. The research presents the first direct evidence of this transmission pathway taking place in hospital patients.

It's assumed that as we get older our health will deteriorate. Our bodies age, wrinkles form, metabolism slows, and our immune system weakens. But how much of what we consider to simply be natural aging is actually due to preventable environmental factors?

Australia's Therapeutic Goods Administration has granted approval to a fecal transplant therapy designed to target a serious bacterial infection, marking the first time any regulatory body in the world has formally authorized this kind of microbiome therapy.

In the first study to investigate the effect of repeat SARS-CoV-2 infections on a person's general health researchers have found COVID reinfections can increase one's risk of neurological diseases, diabetes, lung problems and heart disease.

A survey of nearly 1,000 long COVID patients has found 89% of respondents have not returned to their pre-COVID level of health, a year after their acute infection. The study highlights the persistent lingering impact COVID is having on many people.

In the first big real-world test for monoclonal antibodies against malaria a new study has reported extraordinarily promising results, with a novel therapy found to be 88.2% effective at preventing infections across a six-month period.

A striking new case study illustrates just how pervasive SARS-CoV-2 aerosol transmission can be, describing a trio of infections in a Taiwan quarantine hotel with the virus likely traveling through walls and floors in a poorly ventilated building.

It's been a rough week for nose-pickers, with headlines loudly declaring "scary evidence" has been found linking Alzheimer's disease to a bit of finger-based nasal exploration. But what is the evidence behind this bold claim and is it really a problem?

After decades of research a long-awaited vaccine against RSV is close after preliminary Phase 3 data revealed maternal immunization with a new vaccine delivered extraordinary protection from severe disease in babies across their first months of life.

New research suggests around one-third of people suffering from COVID-19 could experience a rebound in symptoms days after initially recovering. The research follows growing reports of disease recurrence after antiviral treatment with Paxlovid.

Toxoplasma gondii is a common parasite in humans, but exactly how it’s so good at spreading has been murky. Now scientists at Stockholm University have uncovered a sneaky Trojan horse technique that allows it to avoid the immune system.

Urinary tract infections (UTIs) are common and treatable, but there can be complications, especially when the bacteria become drug resistant. Now, a new drug combo has shown promise in a Phase 3 clinical trial.